Automated Accounts Payable provider Glantus Holdings raises 14M and successfully floats on AIM. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 98.90
Bid: 98.75
Ask: 99.30
Change: 0.00 (0.00%)
Spread: 0.55 (0.56%)
Open: 100.10
High: 100.90
Low: 97.00
Yest. Close: 100.10
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Synairgen Raises GBP80 Million In Placing, To Launch Open Offer

Thu, 15th Oct 2020 11:39

(Alliance News) - Synairgen PLC on Thursday said it has raised GBP80.0 million in a share placing.

The respiratory drug discovery and development company placed 45.7 million shares at 175.00 pence each, with the price representing a 4.1% discount to the volume-weighted average share price in the ten days up to and including Wednesday.

Shares in Synairgen were down 11% at 201.80p each on Thursday. The stock closed at 226p on Wednesday. The company has a market capitalisation of GBP301.6 million.

The proceeds will be used to support its phase 3 trial clinical trial in Covid-19 patients, support SNG001 manufacturing and device scale up, generate further SNG001 data and strengthen its balance sheet.

"Having demonstrated the great promise of SNG001 in hospitalised Covid-19 patients earlier this year, we are delighted to have now received the financial support to be able to progress this potential breakthrough treatment in such a critical area of unmet need," said Chief Executive Richard Marsden.

Synairgen added that it will launch an open offer to qualifying shareholders to raise up to GBP7.0 million, on the basis of one open offer share for every 37 existing shares.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

TRADING UPDATES: Vertu Motors profit jumps; Mears swings to 2020 loss

TRADING UPDATES: Vertu Motors profit jumps; Mears swings to 2020 loss

12 May 21 14:26

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

30 Apr 21 14:15

Synairgen confirms start of dosing in Covid-19 trial

(Sharecast News) - Respiratory drug discovery and development company Synairgen announced on Monday that dosing has started in the inhaled interferon beta formulation 'SNG001' sub-study of the 'ACTIV-2' phase 2 and 3 trial, evaluating patients with mild-to-moderate Covid-19 symptoms not yet requiring hospitalisation.

15 Feb 21 11:57

IN BRIEF: Synairgen Begins Dosing Of Covid Patients In SNG001 Sub-Study

IN BRIEF: Synairgen Begins Dosing Of Covid Patients In SNG001 Sub-Study

15 Feb 21 10:52

TRADING UPDATES: Intuitive Plots GBP250,000 Investment In Microsaic

TRADING UPDATES: Intuitive Plots GBP250,000 Investment In Microsaic

25 Jan 21 19:18

IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial

IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial

20 Jan 21 21:16

Synairgen Doses First Patient In Covid-19 Treatment Trial

Synairgen Doses First Patient In Covid-19 Treatment Trial

13 Jan 21 10:24

COVID SCIENCE-COVID-19 patients still have symptoms 6 months later; interferon may be helpful treatment after all

By Nancy LapidJan 11 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Half a year later, COVID-19 pat...

11 Jan 21 20:54

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

18 Dec 20 12:08

Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine

Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine

18 Dec 20 11:06

Synairgen makes solid progress with Covid-19 treatment

(Sharecast News) - Respiratory drug development company Synairgen updated the market on its phase 3 trial design evaluating SNG001 as a treatment for patients with Covid-19 on Friday, as well as positive progress on its regulatory path.

18 Dec 20 10:29

finnCap Interim Profit More Than Doubles; Chair To Step Down

finnCap Interim Profit More Than Doubles; Chair To Step Down

18 Nov 20 13:59

Synairgen surges on positive results for Covid-19 treatment

(Sharecast News) - Synairgen shares surged on Friday after data from trials of its inhaled Covid-19 treatment, SNG001, published in The Lancet Respiratory Medicine, showed positive results in hospitalised patients.

13 Nov 20 14:28

Synairgen Drug Helps Recovery In Hospitalised Covid-19 Patients

Synairgen Drug Helps Recovery In Hospitalised Covid-19 Patients

13 Nov 20 10:24

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

2 Nov 20 20:03

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.